Co-Authors
This is a "connection" page, showing publications co-authored by David Navarro and Roberto Gozalbo-Rovira.
Connection Strength
2.080
-
SARS-CoV-2 antibodies, serum inflammatory biomarkers and clinical severity of hospitalized COVID-19 patients. J Clin Virol. 2020 10; 131:104611.
Score: 0.901
-
SARS-CoV-2 N-antigenemia in critically ill adult COVID-19 patients: Frequency and association with inflammatory and tissue-damage biomarkers. J Med Virol. 2022 01; 94(1):222-228.
Score: 0.241
-
Adaptive immune responses to SARS-CoV-2 in recovered severe COVID-19 patients. J Clin Virol. 2021 09; 142:104943.
Score: 0.240
-
Lower respiratory tract and plasma SARS-CoV-2 RNA load in critically ill adult COVID-19 patients: Relationship with biomarkers of disease severity. J Infect. 2021 09; 83(3):381-412.
Score: 0.237
-
Inference of SARS-CoV-2 spike-binding neutralizing antibody titers in sera from hospitalized COVID-19 patients by using commercial enzyme and chemiluminescent immunoassays. Eur J Clin Microbiol Infect Dis. 2021 Mar; 40(3):485-494.
Score: 0.231
-
Suitability of two rapid lateral flow immunochromatographic assays for predicting SARS-CoV-2 neutralizing activity of sera. J Med Virol. 2021 04; 93(4):2301-2306.
Score: 0.230